HPV and cervical cancer

Around 13 high-risk types of HPV are responsible for causing cervical cancers [1]. Within the high-risk group, types 16 and 18 are the most prevalent, causing over 70% of cervical cancers [2].

An HPV infection causes changes to the cells of the cervix, creating abnormalities; it affects the DNA in the cells, meaning any new cells created will also be abnormal. HPV attacks the basal cells of the cervix (these are specific cells found in skin that reproduce new skin cells) [3]. These abnormalities can result in the production of damaged and disorganised cervical cells that cannot function correctly.

Four out of five (80%) women are infected with genital HPV at some point in their lives without ever knowing they have been infected because HPV is usually cleared (without treatment) by the body's immune system, with 80% of cells healing within two years (see pathway 1 in the figure below) [4].

However, a small percentage of women do not clear the infection and it can remain 'dormant' (inactive) or persistent in their bodies, sometimes for many years [5] [6]. If your immune system doesn't clear the infection and/or the abnormal cells are not removed or monitored, the DNA of the HPV virus can join with the DNA of the epithelial cells, creating cancer cells (see pathway 2 in the figure below). This is why cervical screening and HPV vaccination are important in helping to spot abnormalities and prevent cancer.

We still don't understand why some women are able to clear the infection, while in others the virus may lead to the development of abnormal cells and possibly cervical cancer.

HPV and Cervical Cancer


References

  1. Li N et al., 2011. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. International Journal of Cancer 128, 927–935.
  2. Bosch FX et al., 2008. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 26 (Suppl. 10), K1–K16
  3. Dunleavey R, 2009. Cervical cancer: a guide for nurses. John Wiley & Sons, West Sussex, UK.
  4. Safaeian M et al., 2008. Determinants of incidence and clearance of high-risk HPV infections in rural Rakai, Uganda. Cancer Epidemiology, Biomarkers & Prevention 17 (6), 1300–1307.
  5. Muñoz N et al., 2009. Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women. British Journal of Cancer 100, 1184–1190.
  6. Moscicki AB et al., 1998. The natural history of human papillomavirus infection as measured by repeat DNA testing in adolescent and young women. Journal of Pediatrics 132, 277–284.
Date last updated: 
19 May 2015
Date due for review: 
19 May 2018

Information Standard logo

Have a question? Need to talk?

Our helpline is currently closed, find out when it’s next open.

Or submit your question via our Ask the Expert online service

Rate the information on this page

When you click on an answer below, your vote will be submitted automatically. We do also ask that you please submit a comment and click ‘send feedback’ to provide comment about our information.

Do you feel more informed after reading this information?
I found all the information I needed on this page (1 = Strongly disagree > 5 = Strongly agree)
Rate this page
You voted: . Total votes: 91. Average rating: 3.34